Biblio

Export 1530 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
R. Nie, Wu, Z., Ni, J., Zeng, F., Yu, W., Zhang, Y., Kadowaki, T., Kashiwazaki, H., Teeling, J. L., and Zhou, Y., “Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages.”, J Alzheimers Dis, vol. 72, no. 2, pp. 479-494, 2019.
R. Nie, Wu, Z., Ni, J., Zeng, F., Yu, W., Zhang, Y., Kadowaki, T., Kashiwazaki, H., Teeling, J. L., and Zhou, Y., “Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages.”, J Alzheimers Dis, vol. 72, no. 2, pp. 479-494, 2019.
W. Huang, Zeng, F., Gu, Y., Jiang, M., Zhang, X., Yan, X., Kadowaki, T., Mizutani, S., Kashiwazaki, H., Ni, J., and Wu, Z., “Porphyromonas Gingivalis Infection Induces Synaptic Failure via Increased IL-1β Production in Leptomeningeal Cells.”, J Alzheimers Dis, vol. 83, no. 2, pp. 665-681, 2021.
W. Huang, Zeng, F., Gu, Y., Jiang, M., Zhang, X., Yan, X., Kadowaki, T., Mizutani, S., Kashiwazaki, H., Ni, J., and Wu, Z., “Porphyromonas Gingivalis Infection Induces Synaptic Failure via Increased IL-1β Production in Leptomeningeal Cells.”, J Alzheimers Dis, vol. 83, no. 2, pp. 665-681, 2021.
B. Bahar, Kanagasingam, S., Tambuwala, M. M., Aljabali, A. A. A., Dillon, S. A., Doaei, S., Welbury, R., Chukkapalli, S. S., and Singhrao, S. K., “Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.”, J Alzheimers Dis, vol. 82, no. 3, pp. 1259-1275, 2021.
M. Khondoker, Rafnsson, S. Bjorn, Morris, S., Orrell, M., and Steptoe, A., “Positive and Negative Experiences of Social Support and Risk of Dementia in Later Life: An Investigation Using the English Longitudinal Study of Ageing.”, J Alzheimers Dis, vol. 58, no. 1, pp. 99-108, 2017.
C. Lomiguen, Vidal, L., Kozlowski, P., Prancan, A., and Stern, R., “Possible Role of Chitin-Like Proteins in the Etiology of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 2, pp. 439-444, 2018.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., “Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
B. Seok Ye, Lee, Y., Kwak, K., Park, Y. - H., Ham, J. Hyun, Lee, J. Jung, Shin, N. - Y., Lee, J. - M., Sohn, Y. H., and Lee, P. Hyu, “Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 4, pp. 1237-43, 2016.
L. Guo, Rezvanian, A., Kukreja, L., Hoveydai, R., Bigio, E. H., Mesulam, M. - M., Khoury, J. El, and Geula, C., “Postmortem Adult Human Microglia Proliferate in Culture to High Passage and Maintain Their Response to Amyloid-β.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1157-1167, 2016.
L. Guo, Rezvanian, A., Kukreja, L., Hoveydai, R., Bigio, E. H., Mesulam, M. - M., Khoury, J. El, and Geula, C., “Postmortem Adult Human Microglia Proliferate in Culture to High Passage and Maintain Their Response to Amyloid-β.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1157-1167, 2016.
M. Bulk, Kenkhuis, B., van der Graaf, L. M., Goeman, J. J., Natté, R., and van der Weerd, L., “Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease.”, J Alzheimers Dis, 2018.
Y. - Y. Huang, Chen, S. - D., Leng, X. - Y., Kuo, K., Wang, Z. - T., Cui, M., Tan, L., Wang, K., Dong, Q., and Yu, J. - T., “Post-Stroke Cognitive Impairment: Epidemiology, Risk Factors, and Management.”, J Alzheimers Dis, vol. 86, no. 3, pp. 983-999, 2022.
H. Kikuchi, Takahashi, M., Komatsu, H., and Axelsen, P. H., “Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal.”, J Alzheimers Dis, vol. 92, no. 2, pp. 499-511, 2023.
H. Kikuchi, Takahashi, M., Komatsu, H., and Axelsen, P. H., “Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal.”, J Alzheimers Dis, vol. 92, no. 2, pp. 499-511, 2023.
S. Marcolini, Rojczyk, P., Seitz-Holland, J., Koerte, I. K., Alosco, M. L., and Bouix, S., “Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1427-1448, 2023.
S. Fowler-Davis, Barnett, D., Kelley, J., and Curtis, D., “Potential for Digital Monitoring to Enhance Wellbeing at Home for People with Mild Dementia and Their Family Carers.”, J Alzheimers Dis, vol. 73, no. 3, pp. 867-872, 2020.
D. M. Cairns, Itzhaki, R. F., and Kaplan, D. L., “Potential Involvement of Varicella Zoster Virus in Alzheimer's Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1189-1200, 2022.
F. K. Kok, van Leerdam, S. L., and de Lange, E. C. M., “Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.”, J Alzheimers Dis, vol. 87, no. 1, pp. 51-81, 2022.
G. K. Wilcock, Gauthier, S., Frisoni, G. B., Jia, J., Hardlund, J. H., Moebius, H. J., Bentham, P., Kook, K. A., Schelter, B. O., Wischik, D. J., Davis, C. S., Staff, R. T., Vuksanovic, V., Ahearn, T., Bracoud, L., Shamsi, K., Marek, K., Seibyl, J., Riedel, G., Storey, J. M. D., Harrington, C. R., and Wischik, C. M., “Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.”, J Alzheimers Dis, vol. 61, no. 1, pp. 435-457, 2018.
T. Yamasaki, Horie, S., Ohyagi, Y., Tanaka, E., Nakamura, N., Goto, Y., Kanba, S., Kira, J. - I., and Tobimatsu, S., “A Potential VEP Biomarker for Mild Cognitive Impairment: Evidence from Selective Visual Deficit of Higher-Level Dorsal Pathway.”, J Alzheimers Dis, vol. 53, no. 2, pp. 661-76, 2016.
T. Yamasaki, Horie, S., Ohyagi, Y., Tanaka, E., Nakamura, N., Goto, Y., Kanba, S., Kira, J. - I., and Tobimatsu, S., “A Potential VEP Biomarker for Mild Cognitive Impairment: Evidence from Selective Visual Deficit of Higher-Level Dorsal Pathway.”, J Alzheimers Dis, vol. 53, no. 2, pp. 661-76, 2016.
D. Wucherer, Eichler, T., Hertel, J., Kilimann, I., Richter, S., Michalowsky, B., Thyrian, J. René, Teipel, S., and Hoffmann, W., “Potentially Inappropriate Medication in Community-Dwelling Primary Care Patients who were Screened Positive for Dementia.”, J Alzheimers Dis, vol. 55, no. 2, pp. 691-701, 2017.
Q. Tao, Zhu, H., Chen, X., Stern, R. A., Kowall, N., Au, R., Blusztajn, J. Krzysztof, and Qiu, W. Qiao, “Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 597-609, 2018.
D. E. Bredesen, Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Kurakin, A., and Jarrett, M., “Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications.”, J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.

Pages